369 related articles for article (PubMed ID: 30276203)
1. Microarray-Based Detection and Clinical Evaluation for
Song Y; Dou F; Zhou Z; Yang N; Zhong J; Pan J; Liu Q; Zhang J; Wang S
Biomed Res Int; 2018; 2018():2684836. PubMed ID: 30276203
[No Abstract] [Full Text] [Related]
2. Gastric Juice-Based Real-Time PCR for Tailored
Peng X; Song Z; He L; Lin S; Gong Y; Sun L; Zhao F; Gu Y; You Y; Zhou L; Zhang J
Int J Med Sci; 2017; 14(6):595-601. PubMed ID: 28638276
[TBL] [Abstract][Full Text] [Related]
3. Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study.
Phiphatpatthamaamphan K; Vilaichone RK; Siramolpiwat S; Tangaroonsanti A; Chonprasertsuk S; Bhanthumkomol P; Pornthisarn B; Mahachai V
Asian Pac J Cancer Prev; 2016; 17(4):1903-7. PubMed ID: 27221874
[TBL] [Abstract][Full Text] [Related]
4. High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand.
Prapitpaiboon H; Mahachai V; Vilaichone RK
Asian Pac J Cancer Prev; 2015; 16(10):4353-6. PubMed ID: 26028098
[TBL] [Abstract][Full Text] [Related]
5. Effect of CYP2C19 Gene Polymorphisms on Proton Pump Inhibitor, Amoxicillin, and Levofloxacin Triple Therapy for Eradication of Helicobacter Pylori.
Lin YA; Wang H; Gu ZJ; Wang WJ; Zeng XY; Du YL; Ying SS; Zhang BH
Med Sci Monit; 2017 Jun; 23():2701-2707. PubMed ID: 28577017
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of eradication regimen based on the bacterial susceptibility and CYP2C19 genotype in children with refractory
Zhang YD; Dong QW; Zhang SH; Gu F; Zhang Y; Song HB; Zuo NY; Zhang SS; Ma L; Ding ZL
Zhonghua Er Ke Za Zhi; 2020 Jan; 58(1):41-45. PubMed ID: 31905475
[No Abstract] [Full Text] [Related]
7. Simultaneous detection of human CYP2C19 polymorphisms and antibiotic resistance of Helicobacter pylori using a personalised diagnosis kit.
Zhang J; Zhong J; Ding J; Shi J; Tang T; Liu Q; Huang H; Dai L; Yang N
J Glob Antimicrob Resist; 2018 Jun; 13():174-179. PubMed ID: 29444465
[TBL] [Abstract][Full Text] [Related]
8. Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis.
Chang YW; Ko WJ; Oh CH; Park YM; Oh SJ; Moon JR; Cho JH; Kim JW; Jang JY
Korean J Intern Med; 2019 Sep; 34(5):1022-1029. PubMed ID: 29898576
[TBL] [Abstract][Full Text] [Related]
9. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
[TBL] [Abstract][Full Text] [Related]
10. Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or for tailored therapy.
Prasertpetmanee S; Mahachai V; Vilaichone RK
Helicobacter; 2013 Aug; 18(4):270-3. PubMed ID: 23356886
[TBL] [Abstract][Full Text] [Related]
11. High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam.
Phan TN; Santona A; Tran VH; Tran TN; Le VA; Cappuccinelli P; Rubino S; Paglietti B
Int J Antimicrob Agents; 2015 Mar; 45(3):244-8. PubMed ID: 25499186
[TBL] [Abstract][Full Text] [Related]
12. Application of Visual Gene Clip-Based Tailored Therapy for the Eradication of
Yang L; Zou A; Wu H; Guo H; Zhang F; Zou B; Wang J
Biomed Res Int; 2021; 2021():6150628. PubMed ID: 33937401
[TBL] [Abstract][Full Text] [Related]
13. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
Song Z; Zhou L; Zhang J; He L; Bai P; Xue Y
Dig Liver Dis; 2016 May; 48(5):506-511. PubMed ID: 26847964
[TBL] [Abstract][Full Text] [Related]
14. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
Miftahussurur M; Shrestha PK; Subsomwong P; Sharma RP; Yamaoka Y
BMC Microbiol; 2016 Nov; 16(1):256. PubMed ID: 27809767
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.
Dekhnich N; Ivanchik N; Kozlov R; Alimov A; Steshits A; Kirsov P; Pandav K
Helicobacter; 2018 Dec; 23(6):e12545. PubMed ID: 30324756
[TBL] [Abstract][Full Text] [Related]
16. Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin.
Oh JH; Dong MS; Choi MG; Yoo HW; Lee SB; Park YI; Chung IS
J Gastroenterol Hepatol; 2009 Feb; 24(2):294-8. PubMed ID: 18823430
[TBL] [Abstract][Full Text] [Related]
17. Influence of CYP2C19 on Helicobacter pylori eradication in Brazilian patients with functional dyspepsia.
Nabinger DD; Mazzoleni LE; Sander GB; Mazzoleni F; Osório MC; Klein MG; Rech TF; Basso da Silva L; de Moraes GS; Cristovam RA; Nardelli EF; Francesconi CF; Simon D
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706745
[TBL] [Abstract][Full Text] [Related]
18. Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole.
Ormeci A; Emrence Z; Baran B; Gokturk S; Soyer OM; Evirgen S; Akyuz F; Karaca C; Besisik F; Kaymakoglu S; Ustek D; Demir K
Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):879-85. PubMed ID: 27010145
[TBL] [Abstract][Full Text] [Related]
19. CYP2C19 polymorphism influences Helicobacter pylori eradication.
Kuo CH; Lu CY; Shih HY; Liu CJ; Wu MC; Hu HM; Hsu WH; Yu FJ; Wu DC; Kuo FC
World J Gastroenterol; 2014 Nov; 20(43):16029-36. PubMed ID: 25473155
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.
Lee JY; Kim N; Kim MS; Choi YJ; Lee JW; Yoon H; Shin CM; Park YS; Lee DH; Jung HC
Dig Dis Sci; 2014 Jun; 59(6):1235-43. PubMed ID: 24599773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
